NEW YORK (GenomeWeb) – Sophia Genetics said today that it has obtained the CE-IVD Mark for its next-generation sequencing bioinformatics pipeline for routine genetic testing.
The CE-IVD Mark enables the Lausanne, Switzerland-based firm to offer the pipeline in all markets accepting the CE mark in Europe, Latin America, Middle East, Africa, and Asia. Sophia said that it will also seek to obtain the CE Mark for all of the genetic tests it supports.